T1	Condition 53 68	dry eye disease
T2	Condition-Name 53 68	dry eye disease
E1	Condition:T1 Name:T2 Temporality:E15 Duration:E4
T3	Condition 158 165	dry eye
T4	Condition-Name 158 165	dry eye
E3	Condition:T3 Name:T4
T5	Condition 582 598	systemic disease
T6	Condition-Name 582 598	systemic disease
E5	Condition:T5 Name:T6
T7	Procedure 748 761	birth control
T8	Procedure-Name 748 761	birth control
E7	Procedure:T7 Name:T8 Temporality:E20
T9	Condition 655 664	pregnancy
T10	Condition-Name 655 664	pregnancy
E9	Condition:T9 Name:T10
T11	Condition 633 640	nursing
T12	Condition-Name 633 640	nursing
E11	Condition:T11 Name:T12
T13	Eq-Operator 196 197	≥
A1	Eq-Operator-Value T13 GTEQ
T14	Eq-Operator 527 533	within
A2	Eq-Operator-Value T14 LTEQ
T15	Eq-Operator 1103 1109	within
A3	Eq-Operator-Value T15 LTEQ
T16	Eq-Temporal-Unit 97 103	months
A4	Eq-Temporal-Unit-Value T16 month
T17	Eq-Temporal-Unit 537 543	months
A5	Eq-Temporal-Unit-Value T17 month
T18	Eq-Temporal-Unit 1113 1117	days
A6	Eq-Temporal-Unit-Value T18 day
T19	Eq-Value 95 96	6
T20	Eq-Value 197 199	40
T22	Eq-Value 534 536	12
T24	Eq-Value 1110 1112	45
T26	Eq-Comparison 196 199	≥40
E12	Eq-Comparison:T26 Operator:T13 Value:T20
T27	Eq-Comparison 527 543	within 12 months
E13	Eq-Comparison:T27 Operator:T14 Temporal-Unit:T17 Value:T22
T28	Eq-Comparison 1103 1117	within 45 days
E14	Eq-Comparison:T28 Operator:T15 Temporal-Unit:T18 Value:T24
T29	Eq-Comparison 42 49	history
E15	Eq-Comparison:T29 Temporal-Period:T30
T30	Eq-Temporal-Period 42 49	history
A7	Eq-Temporal-Period-Value T30 past
T31	Eq-Comparison 110 117	History
E16	Eq-Comparison:T31 Temporal-Period:T32
T32	Eq-Temporal-Period 110 117	History
A8	Eq-Temporal-Period-Value T32 past
T33	Eq-Comparison 377 385	previous
E17	Eq-Comparison:T33 Temporal-Period:T34
T34	Eq-Temporal-Period 377 385	previous
A9	Eq-Temporal-Period-Value T34 past
T35	Eq-Comparison 490 497	history
E18	Eq-Comparison:T35 Temporal-Period:T36
T36	Eq-Temporal-Period 490 497	history
A10	Eq-Temporal-Period-Value T36 past
T37	Eq-Comparison 994 1003	currently
E19	Eq-Comparison:T37 Temporal-Period:T38
T38	Eq-Temporal-Period 994 1003	currently
A11	Eq-Temporal-Period-Value T38 present
T39	Eq-Comparison 719 724	using
E20	Eq-Comparison:T39 Temporal-Period:T40
T40	Eq-Temporal-Period 719 724	using
A12	Eq-Temporal-Period-Value T40 present
T41	Temporal-Connection 1118 1123	prior
E21	Temporal-Connection:T41 Arg:E14 Arg2:E62
T43	Modifier 72 81	both eyes
E2	Modifier:T43 Modifies:T2
T44	Eq-Comparison 86 103	at least 6 months
E4	Eq-Comparison:T44 Operator:T45 Value:T19 Temporal-Unit:T16
T45	Eq-Operator 86 94	at least
A14	Eq-Operator-Value T45 GTEQ
T46	Procedure 128 153	artificial tear eye drops
E6	Procedure:T46 Name:T47 Temporality:E16
T47	Procedure-Name 128 153	artificial tear eye drops
T48	Assertion 166 174	symptoms
E8	Assertion:T48 Asserted:E3
A15	Assertion-Type-Value E8 possible
R1	Treatment-For Arg1:E6 Arg2:E3	
T49	Observation 203 208	SANDE
E22	Observation:T49 Name:T50 Eq-Comparison:E12
T50	Observation-Name 203 208	SANDE
T51	Observation 215 220	TFBUT
E10	Observation:T51 Name:T52
T52	Observation-Name 215 220	TFBUT
T53	Condition 227 255	Corneal fluorescein staining
E23	Condition:T53 Name:T54
T54	Condition-Name 227 255	Corneal fluorescein staining
T55	Condition 278 299	conjunctival staining
E24	Condition:T55 Name:T56
T56	Condition-Name 278 299	conjunctival staining
T57	Modifier 262 277	Lissamine green
E25	Modifier:T57 Modifies:T56
T58	Observation 306 321	Schirmer's test
E26	Observation:T58 Name:T59
T59	Observation-Name 306 321	Schirmer's test
T60	Drug 386 397	tavilermide
E27	Drug:T60 Name:T61 Temporality:E17
T61	Drug-Name 386 397	tavilermide
T62	Drug 399 405	MIM-D3
E28	Drug:T62 Name:T63
T63	Drug-Name 399 405	MIM-D3
R2	Abbrev-Of Arg1:E28 Arg2:E27	
T64	Study 407 412	study
E29	Study:T64 Study-Of:E28
T21	Condition 447 465	slit lamp findings
E30	Condition:T21 Name:T65
T65	Condition-Name 447 465	slit lamp findings
T66	Study 469 474	Visit
E31	Study:T66 
T67	Temporal-Connection 466 468	at
E32	Temporal-Connection:T67 Arg:E30 Arg2:E31
A16	Temporal-Connection-Type-Value E32 during
T68	Condition 501 526	lacrimal duct obstruction
E33	Condition:T68 Name:T69 Temporality:E18 Temporality2:E13
T69	Condition-Name 501 526	lacrimal duct obstruction
T23	Study 547 552	Visit
E34	Study:T23 
T70	Temporal-Connection 544 546	of
E35	Temporal-Connection:T70 Arg:E13 Arg2:E34
A17	Temporal-Connection-Type-Value E35 before
T71	Modifier 569 581	uncontrolled
E36	Modifier:T71 Modifies:E5
T72	Life-Stage-And-Gender 610 615	woman
A18	Life-Stage-And-Gender-Type T72 female
T73	Condition 623 631	pregnant
E37	Condition:T73 Name:T74
T74	Condition-Name 623 631	pregnant
T75	And 616 619	who
E38	And:T75 Arg:T72 Arg2:E37
T76	Assertion 644 652	planning
E39	Assertion:T76 Asserted:E9
A19	Assertion-Type-Value E39 intention
T77	Or 641 643	or
E40	Or:T77 Arg:E11 Arg2:E39
T78	Life-Stage-And-Gender 676 681	woman
A20	Life-Stage-And-Gender-Type T78 female
T79	Condition 685 707	childbearing potential
E41	Condition:T79 Name:T80
T80	Condition-Name 685 707	childbearing potential
T81	And 682 684	of
E42	And:T81 Arg:T78 Arg2:E41
T82	Negation 715 718	not
E43	Negation:T82 Negates:E7
T83	And 708 711	who
E44	And:T83 Arg:E41 Arg2:E43
T84	Condition 775 784	condition
E45	Condition:T84 
T85	Risk 870 874	risk
E46	Risk:T85 Severity:T86
R3	Caused-By Arg1:E46 Arg2:E45	
T86	Severity 858 869	significant
A21	Severity-Value T86 severe
T87	Study 893 898	study
E47	Study:T87 Stability:T88
T88	Stability 880 888	confound
A22	Stability-Value T88 change
R4	Caused-By Arg1:T88 Arg2:E45	
T89	Assertion 876 879	may
E48	Assertion:T89 Asserted:T88
A23	Assertion-Type-Value E48 hypothetical
T90	Study 979 984	study
E49	Study:T90 Stability:T91
T91	Stability 915 924	interfere
A24	Stability-Value T91 change
T92	Assertion 911 914	may
E50	Assertion:T92 Asserted:T91
A25	Assertion-Type-Value E50 hypothetical
T93	Or 908 910	or
E51	Or:T93 Arg:E47 Arg2:E50
R5	Caused-By Arg1:T91 Arg2:E45	
T94	Study 1050 1055	study
E52	Study:T94 Study-Of:E54 Temporality:E19
T95	Drug 1035 1039	drug
E53	Drug:T95 
T96	Procedure 1043 1049	device
E54	Procedure:T96 
T97	Or 1040 1042	or
E55	Or:T97 Arg:E53 Arg2:E54
T98	Drug 1088 1092	drug
E56	Drug:T98 
T99	Procedure 1096 1102	device
E57	Procedure:T99 Temporality:E14
T100	Study 1072 1087	investigational
E58	Study:T100 Temporality:E59 Study-Of:E56
T101	Eq-Comparison 1064 1068	used
E59	Eq-Comparison:T101 Temporal-Period:T102
T102	Eq-Temporal-Period 1064 1068	used
A26	Eq-Temporal-Period-Value T102 past
T103	Or 1056 1058	or
E60	Or:T103 Arg:E52 Arg2:E58
T104	Or 1093 1095	or
E61	Or:T104 Arg:E56 Arg2:E57
A13	Temporal-Connection-Type-Value E21 before
T25	Study 1127 1132	Visit
E62	Study:T25 
